Codexis, Inc. (CDXS) Named Finalist for CPhI Pharma Award for Best Innovation in Process Development
10/3/2013 10:33:12 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that it has been named as a finalist for the CPhI Pharma Awards in the “Best Innovation in Process Development” category. The award ceremony will take place on October 22, 2013 in Frankfurt, Germany as part of the annual CPhI Worldwide exhibition, which is expected to attract around 30,000 visitors from the pharmaceutical industry.
Help employers find you! Check out all the jobs and post your resume.